Jeremy Hayden - Jan 1, 2023 Form 4 Insider Report for Sight Sciences, Inc. (SGHT)

Signature
/s/ Jeremy Hayden
Stock symbol
SGHT
Transactions as of
Jan 1, 2023
Transactions value $
-$14,756
Form type
4
Date filed
1/5/2023, 05:30 AM
Previous filing
Feb 11, 2022
Next filing
Mar 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGHT Common Stock Award $0 +12K $0.00 3K Jan 1, 2023 Direct F1, F2
transaction SGHT Common Stock Tax liability -$14.8K -1.19K -39.73% $12.38 1.81K Jan 4, 2023 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on February 9, 2022 under the Issuer's 2021 Incentive Award Plan (such grant, the "2022 RSU Grant"), as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on February 11, 2022. Of the RSUs awarded to the Reporting Person under the 2022 RSU Grant, 25% vested on January 1, 2023, and an additional 25% vest on each of January 1, 2024, 2025, and 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The RSUs have no expiration date.
F2 Includes 3,000 shares of Common Stock issued in connection with the January 1, 2023 vesting of the 2022 RSU Grant.
F3 Reflects shares of Common Stock sold to cover the Reporting Person's tax liability in connection with the vesting of RSUs.
F4 Reflects the weighted average price at which the shares were sold. The shares were sold in multiple transactions at prices ranging from $12.16 to $12.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.